BCL11B and severe combined immunodeficiency: In this sense, attempts of restoring BCL11B function with antisense oligonucleotides in animal models of SCID have been made and pave the way for genome editing [6].Considering that BCL11B haploinsufficiency has leukemogenic effects, further studies should also address the regulation of BCL11B expression at the molecular level.